| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aclaris Therapeutics, Inc. (ACRS) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 33 sells. ACRS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 13.95M | $65.56M | - | |
| Other | 510.0K | $2.40M | - | |
| COO | 336.3K | $1.58M | - | |
| CEO | 274.8K | $1.29M | - | |
| Other | 18.7K | $87.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 13, 2021 | Gordon David N.65 | Chief Medical Officer | Sell | 2,631 | $16.98 | $44,674.64 | -1.8% | +4.5% | -6.0% | |
| Jun 3, 2021 | Ali-Jackson Kamil71 | Chief Legal Officer | Sell | 9,492 | $21.96 | $208,420.59 | -7.2% | -21.4% | -32.6% | |
| Jun 2, 2021 | Gordon David N.65 | Chief Medical Officer | Sale+OE | 51,914 | $22.01 | $1,142,374.61 | -7.3% | -25.4% | -33.4% | |
| Jun 2, 2021 | Monahan Joseph87 | Chief Scientific Officer | Sale+OE | 21,790 | $21.64 | $471,436.61 | -11.1% | -25.4% | -33.4% | |
| Jun 2, 2021 | Ruffo Frank74 | Chief Financial Officer | Sale+OE | 15,037 | $21.64 | $325,382.63 | -4.2% | -25.4% | -33.4% | |
| Jun 2, 2021 | Walker Neal85 | President And CEO | Sale+OE | 33,260 | $21.64 | $719,734.92 | -1.3% | -25.4% | -33.4% | |
| Jun 2, 2021 | Ali-Jackson Kamil71 | Chief Legal Officer | Sale+OE | 45,119 | $22.10 | $996,963.10 | -4.8% | -25.4% | -33.4% | |
| May 7, 2021 | Ali-Jackson Kamil71 | Chief Legal Officer | Sale+OE | 20,416 | $23.45 | $478,844.96 | -3.4% | -35.7% | -48.5% | |
| May 5, 2021 | Ali-Jackson Kamil71 | Chief Legal Officer | Sale+OE | 45,000 | $24.08 | $1,083,718.47 | -4.9% | -38.2% | -48.3% | |
| Apr 26, 2021 | Ruffo Frank74 | Chief Financial Officer | Sell | 87,339 | $26.45 | $2,310,106.14 | -9.1% | -42.0% | -46.0% |